G Holmström1, K Thorén. 1. Department of Ophthalmology, Academic Hospital, Uppsala, Sweden. gerd.holmstrom@ogon.uas.lul.se
Abstract
PURPOSE: The study aimed to evaluate the ocular manifestations in patients with incontinentia pigmenti (IP). METHODS: Thirty patients from different parts of Sweden participated. Orthoptic and ocular examinations were performed as well as evaluation of refraction and visual acuity. RESULTS: Ocular manifestations, probably associated with IP, were found in 77% (23/30) of the patients. Thirteen had serious or vision-threatening eye manifestations in one eye, of whom 7 were totally blind in that eye from retinal detachments. Ten patients had minor retinal and/or corneal changes. CONCLUSION: Ocular lesions in patients with IP may be serious and lead to blindness because of retinal disease. Ophthalmological follow-up is essential in the neonatal period and such a programme is recommended.
PURPOSE: The study aimed to evaluate the ocular manifestations in patients with incontinentia pigmenti (IP). METHODS: Thirty patients from different parts of Sweden participated. Orthoptic and ocular examinations were performed as well as evaluation of refraction and visual acuity. RESULTS: Ocular manifestations, probably associated with IP, were found in 77% (23/30) of the patients. Thirteen had serious or vision-threatening eye manifestations in one eye, of whom 7 were totally blind in that eye from retinal detachments. Ten patients had minor retinal and/or corneal changes. CONCLUSION:Ocular lesions in patients with IP may be serious and lead to blindness because of retinal disease. Ophthalmological follow-up is essential in the neonatal period and such a programme is recommended.
Authors: Jacob Basilius; Marielle P Young; Timothy C Michaelis; Ronald Hobbs; Glen Jenkins; M Elizabeth Hartnett Journal: JAMA Ophthalmol Date: 2015-09 Impact factor: 7.389
Authors: Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal Journal: Am J Med Genet C Semin Med Genet Date: 2020-09-05 Impact factor: 3.359
Authors: Cláudia Schermann Poziomczyk; Júlia Kanaan Recuero; Luana Bringhenti; Fernanda Diffini Santa Maria; Carolina Wiltgen Campos; Giovanni Marcos Travi; André Moraes Freitas; Marcia Angelica Peter Maahs; Paulo Ricardo Gazzola Zen; Marilu Fiegenbaum; Sheila Tamanini de Almeida; Renan Rangel Bonamigo; Ana Elisa Kiszewski Bau Journal: An Bras Dermatol Date: 2014 Jan-Feb Impact factor: 1.896